BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 476438)

  • 1. Treatment of orthostatic hypotension with dihydroergotamine.
    Jennings G; Esler M; Holmes R
    Br Med J; 1979 Aug; 2(6185):307. PubMed ID: 476438
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide.
    Benowitz NL; Byrd R; Schambelan M; Rosenberg J; Roizen MF
    Ann Intern Med; 1980 Mar; 92(3):387-8. PubMed ID: 7356234
    [No Abstract]   [Full Text] [Related]  

  • 3. [A 64 year old female patient with orthostatic hypotension and syncopes].
    Antoni D
    Internist (Berl); 1980 Jan; 21(1):50-3. PubMed ID: 6988368
    [No Abstract]   [Full Text] [Related]  

  • 4. Postural hypotension--pathophysiology and management.
    Bradshaw MJ; Edwards RT
    Q J Med; 1986 Jul; 60(231):643-57. PubMed ID: 2876457
    [No Abstract]   [Full Text] [Related]  

  • 5. Postural hypotension and its management.
    Hawkins S; Prout BJ
    Practitioner; 1982 Mar; 226(1365):420-2, 424, 426. PubMed ID: 7045842
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of orthostatic hypotension with dihydroergotamine and caffeine.
    Hoeldtke RD; Cavanaugh ST; Hughes JD; Polansky M
    Ann Intern Med; 1986 Aug; 105(2):168-73. PubMed ID: 3729199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of orthostatic hypotension.
    Christensen NJ; Hilsted J
    Clin Physiol; 1985; 5 Suppl 5():94-6. PubMed ID: 3914392
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of orthostatic hypotension].
    Oldenburg O; Sack S; Erbel R; Philipp T; Kribben A
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1209-12. PubMed ID: 10572521
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of dihydroergotamine in severe orthostatic hypotension. 16 cases].
    Saïd G
    Presse Med; 1987 May; 16(17):800-3. PubMed ID: 2954090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.
    Thulesius O; Berlin E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):465-7. PubMed ID: 2877953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypotonic orthostatic regulation disorders. Comparison of dihydroergotamine preparations with varying release of effective substances in the management of hypotonic orthostatic regulation disorders].
    Beck J; Schwaiger H
    ZFA (Stuttgart); 1978 Oct; 54(28):1454-9. PubMed ID: 695865
    [No Abstract]   [Full Text] [Related]  

  • 12. Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.
    Olver IN; Jennings GL; Bobik A; Esler M
    Br Med J; 1980 Jul; 281(6235):275-6. PubMed ID: 7427244
    [No Abstract]   [Full Text] [Related]  

  • 13. [A combined therapy with yohimbine and fludrocortisone in idiopathic orthostatic hypotension. A case report].
    Touma T; Muratani H; Takishita S; Fukiyama K
    Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):988-9. PubMed ID: 2794688
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
    Schardt F
    Med Welt; 1981 Feb; 32(6):194-8. PubMed ID: 6110159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dihydroergot plus in the long-term therapy of orthostatic hypotonic dysregulation in older patients].
    Muth HH; Jansen W
    Fortschr Med; 1980 Oct; 98(40):1571-4. PubMed ID: 6109687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 17. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D; Lew M; Claassen D; Goodman BP
    Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
    Polzien P; Bracharz H
    Med Klin; 1980 Dec; 75(25):878-82. PubMed ID: 6110162
    [No Abstract]   [Full Text] [Related]  

  • 19. A new hope in the nightmare of diabetic orthostatic hypotension: the midodrine-fludrocortisone association.
    Andreelli F; Plotton I; Thivolet C; Riou JP
    Diabetes Obes Metab; 1999 Sep; 1(5):297-8. PubMed ID: 11225642
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydroergotamine therapy in symptomatic postural hypotension.
    Bajada S
    Aust N Z J Med; 1979 Dec; 9(6):709-12. PubMed ID: 294931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.